| Quarterly Financials | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 399 | 426 | 425 | 437 | 484 | 555 | 441 | 557 | 539 | 628 | 437 | 533 | 602 | 712 | 607 | 623 | 654 | 773 | 660 | 784 | 803 | 1,017 | 832 | 932 | 883 | 933 | 840 | 908 | 962 | 1,037 | 892 | 926 |
| Expenses | 262 | 280 | 297 | 292 | 327 | 374 | 300 | 325 | 366 | 403 | 297 | 364 | 408 | 443 | 430 | 464 | 438 | 508 | 472 | 552 | 555 | 680 | 596 | 663 | 626 | 600 | 620 | 646 | 660 | 674 | 668 | 711 |
| EBITDA | 138 | 146 | 128 | 145 | 158 | 181 | 142 | 231 | 174 | 225 | 140 | 170 | 193 | 269 | 177 | 160 | 216 | 265 | 188 | 232 | 248 | 337 | 236 | 268 | 257 | 333 | 220 | 261 | 302 | 363 | 224 | 215 |
| Operating Profit % | 33 % | 32 % | 27 % | 30 % | 30 % | 30 % | 29 % | 30 % | 30 % | 34 % | 30 % | 30 % | 30 % | 33 % | 28 % | 24 % | 32 % | 33 % | 27 % | 28 % | 29 % | 32 % | 26 % | 27 % | 27 % | 35 % | 22 % | 27 % | 30 % | 34 % | 24 % | 22 % |
| Depreciation | 35 | 34 | 37 | 40 | 43 | 44 | 47 | 53 | 57 | 62 | 66 | 69 | 70 | 70 | 75 | 76 | 79 | 80 | 86 | 90 | 95 | 96 | 102 | 105 | 108 | 111 | 107 | 111 | 109 | 106 | 111 | 117 |
| Interest | 5 | 7 | 8 | 8 | 8 | 8 | 7 | 8 | 10 | 9 | 7 | 7 | 7 | 7 | 8 | 1 | 9 | 6 | 9 | 12 | 14 | 10 | 11 | 13 | 11 | 13 | 12 | 13 | 12 | 16 | 12 | 13 |
| Profit Before Tax | 98 | 104 | 83 | 97 | 107 | 129 | 87 | 170 | 107 | 153 | 66 | 94 | 117 | 192 | 95 | 82 | 128 | 179 | 93 | 130 | 140 | 231 | 123 | 151 | 138 | 209 | 101 | 137 | 181 | 241 | 101 | 85 |
| Tax | 16 | 20 | 17 | 19 | 20 | 29 | 15 | 42 | 15 | 33 | 8 | 10 | 14 | 32 | 17 | 16 | 24 | 31 | 19 | 28 | 30 | 52 | 30 | 34 | 27 | 20 | 26 | 31 | 50 | 57 | 15 | 18 |
| Net Profit | 82 | 85 | 66 | 78 | 87 | 100 | 72 | 128 | 92 | 120 | 58 | 84 | 102 | 161 | 77 | 67 | 104 | 148 | 74 | 102 | 110 | 179 | 93 | 117 | 112 | 189 | 76 | 106 | 131 | 183 | 87 | 67 |
| EPS in ₹ | 4.14 | 4.27 | 3.34 | 3.96 | 2.20 | 2.53 | 1.82 | 3.23 | 2.32 | 3.03 | 1.47 | 2.12 | 2.57 | 4.04 | 1.91 | 1.64 | 2.57 | 3.71 | 1.85 | 2.55 | 2.74 | 4.36 | 2.33 | 2.90 | 2.78 | 4.70 | 1.89 | 2.64 | 3.27 | 4.56 | 2.16 | 1.67 |
Syngene International
Syngene International
629.25
-5.35
(-0.84%)
Key Fundamentals
Market Cap
25,354.96 Cr
EPS
12.35
PE Ratio
54.60
Dividend Yield
0.20 %
Industry
Healthcare 52 Week High
960.60
52 Week Low
599.55
PB Ratio
5.40
Debt to Equity
0.13
Sector
Healthcare Technology Analyst Rating and Forecast
- By Refinitiv from8 analysts
Actual
Company News
View All News
Syngene International announced that Alex DelPriore, Head of Large Molecules CDMO and Executive Committee member, will leave the company by mutual consent with immediate effect. Dr. Rohtash Kumar has been appointed as Head of CDMO, Small and Large Molecules and Executive Committee member, effective December 1, 2025.
SynGene reported a 263% year-over-year increase in CO exports.
Syngene International Provides FY26 Financial Guidance with Mid-Single Digit Revenue Growth
Nov 07, 2025
Nov 07, 2025Syngene International has issued guidance for FY26, projecting mid-single digit revenue growth in constant currency and mid-20s EBITDA margins, though with declining profit after tax. The company expects capital expenditure of $45 million plus an additional $10 million for the Bayview facility. Raw material costs are projected at around 25% of revenue for the full year, with an effective tax rate of 21-23%. Management maintains their full year guidance and notes historically stronger performance in the second half of the year.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
629.25 | #1 25,354.96 | #9 54.60 | #1 3,714.20 | #6 3.77 | #1 496 | #5 -36.76 | 42.69 | |
510.05 | 12,248.32 | 27.75 | 2,946.50 | 10.53 | 407 | 11.34 | 36.34 | |
176.17 | 4,007.41 | -19.03 | 17.60 | -46.34 | -161 | -55.85 | 35.13 | |
611.45 | 2,723.45 | 45.21 | 322.30 | 0.22 | 41 | 112.87 | 34.75 | |
30.08 | 444.99 | 9.29 | 10.20 | #1 126.67 | 1 | #1 493.75 | 80.89 | |
78.35 | 184.53 | -4.34 | 806.50 | 4.78 | -56 | 22.07 | 29.75 | |
62.17 | 98.41 | #1 -22.09 | 47.50 | 17.87 | 0 | -100.00 | 60.98 | |
16.00 | 23.38 | 33.09 | 84.00 | 5.00 | 2 | -76.92 | 44.04 | |
23.75 | 16.91 | -1.34 | 2.10 | -78.57 | -13 | -450.00 | 45.44 |
Growth Rate
Revenue Growth
3.77 %
Net Income Growth
-2.71 %
Cash Flow Change
12.04 %
ROE
-12.35 %
ROCE
-1.05 %
EBITDA Margin (Avg.)
-2.88 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 |
| Fixed Assets | 1,030 | 1,377 | 2,020 | 2,201 | 2,393 | 2,667 | 2,850 | 2,802 |
| Current Assets | 1,720 | 1,764 | 1,613 | 1,807 | 2,206 | 2,425 | 1,959 | 2,287 |
| Capital Work in Progress | 155 | 274 | 234 | 237 | 346 | 177 | 838 | 1,266 |
| Investments | 158 | 716 | 776 | 702 | 1,034 | 919 | 548 | 647 |
| Other Assets | 1,846 | 1,337 | 1,133 | 1,743 | 1,791 | 2,069 | 1,916 | 2,081 |
| Total Liabilities | 3,189 | 3,704 | 4,163 | 4,883 | 5,564 | 5,831 | 6,152 | 6,796 |
| Current Liabilities | 784 | 1,129 | 1,539 | 1,133 | 1,229 | 1,188 | 1,144 | 1,396 |
| Non Current Liabilities | 685 | 607 | 448 | 929 | 1,037 | 1,025 | 750 | 673 |
| Total Equity | 1,720 | 1,968 | 2,176 | 2,821 | 3,298 | 3,618 | 4,258 | 4,727 |
| Reserve & Surplus | 1,520 | 1,768 | 1,776 | 2,421 | 2,897 | 3,217 | 3,856 | 4,324 |
| Share Capital | 200 | 200 | 400 | 400 | 401 | 401 | 402 | 403 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 18 | -88 | 28 | 130 | -62 | -172 | -4 | 281 |
| Investing Activities | -349 | -646 | -424 | -629 | -611 | -653 | -495 | -744 |
| Operating Activities | 446 | 630 | 677 | 701 | 581 | 824 | 1,042 | 1,168 |
| Financing Activities | -79 | -72 | -226 | 58 | -31 | -343 | -551 | -142 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 70.58 % | 70.43 % | 70.42 % | 70.41 % | 70.41 % | 70.29 % | 64.86 % | 64.86 % | 54.88 % | 54.80 % | 54.79 % | 54.79 % | 54.79 % | 54.72 % | 54.72 % | 52.74 % | 52.74 % | 52.68 % | 52.68 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.02 % | 0.02 % | 0.00 % | 0.00 % | 0.00 % | 20.92 % | 20.63 % | 20.72 % | 20.64 % | 19.47 % | 16.50 % | 16.31 % |
| DIIs | 4.02 % | 3.81 % | 4.03 % | 3.64 % | 3.26 % | 2.79 % | 4.96 % | 7.04 % | 10.73 % | 11.20 % | 9.94 % | 13.08 % | 15.80 % | 16.80 % | 17.48 % | 19.53 % | 21.50 % | 24.05 % | 24.62 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 8.05 % | 8.29 % | 8.46 % | 9.20 % | 9.22 % | 9.02 % | 8.81 % | 8.57 % | 8.39 % | 8.10 % | 7.53 % | 7.24 % | 6.45 % | 6.08 % | 5.45 % | 5.59 % | 5.08 % | 5.59 % | 5.28 % |
| Others | 17.35 % | 17.46 % | 17.09 % | 16.76 % | 17.11 % | 17.90 % | 21.36 % | 19.52 % | 25.98 % | 25.90 % | 27.73 % | 24.89 % | 2.03 % | 1.77 % | 1.62 % | 1.50 % | 1.21 % | 1.18 % | 1.10 % |
| No of Share Holders | 1,15,632 | 1,26,395 | 1,36,749 | 1,37,892 | 1,33,610 | 1,28,278 | 1,34,334 | 1,27,964 | 1,24,014 | 1,25,455 | 1,25,992 | 1,21,880 | 1,15,850 | 1,20,018 | 1,07,338 | 1,28,806 | 1,25,090 | 1,42,310 | 1,36,061 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 1 | 1 | 0.5 | 0.00 | 0.00 | 1 | 1.25 | 1.25 | 1.25 |
| Dividend Yield (%) | 0.00 | 0.33 | 0.34 | 0.21 | 0.00 | 0.00 | 0.17 | 0.18 | 0.17 | 0.2 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Jun 2019 |  Bonus | 1:1 | 11 Jun 2019 | 340.05 | 336.35 |
| 01 Jul 2022 |  Dividend | ₹ 0.50 /share | 30 Jun 2022 | 627.50 | 554.75 |
| 01 Jul 2022 | Dividend | ₹ 0.50 /share | 30 Jun 2022 | 627.50 | 554.75 |
| 30 Jun 2023 | Dividend | ₹ 0.75 /share | 30 Jun 2023 | 625.90 | 759.60 |
| 30 Jun 2023 | Dividend | ₹ 0.50 /share | 30 Jun 2023 | 625.90 | 759.60 |
| 28 Jun 2024 | Dividend | ₹ 1.25 /share | 28 Jun 2024 | 701.05 | 713.15 |
| 24 Jul 2024 |  Annual General Meeting | NA | 24 Jul 2024 | 701.05 | 757.75 |
| 23 Oct 2024 |  Quarterly Result Announcement | NA | 23 Oct 2024 | 884.35 | 838.90 |
| 23 Jan 2025 | Quarterly Result Announcement | NA | 23 Jan 2025 | 859.80 | 828.15 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 697.45 | 735.45 |
| 27 Jun 2025 | Dividend | ₹ 1.25 /share | 27 Jun 2025 | 735.45 | 645.85 |
| 23 Jul 2025 | Quarterly Result Announcement | NA | 23 Jul 2025 | 634.20 | 676.25 |
| 23 Jul 2025 | Annual General Meeting | NA | 23 Jul 2025 | 735.45 | 676.25 |
| 05 Nov 2025 | Quarterly Result Announcement | NA | 05 Nov 2025 | 630.65 | 646.55 |
Announcements
Announcement under Regulation 30 (LODR)-Change in Management4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 06, 2025
Nov 06, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Nov 06, 2025Board Meeting Outcome for Outcome Of The Board Meeting - November 05 2025.Nov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 05, 2025
Nov 05, 2025Unaudited Financial Results For The Quarter & Half Year Ended September 30 2025.Nov 05, 2025
Nov 05, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 31, 2025
Oct 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 28, 2025
Oct 28, 2025Rumour verification - Regulation 30(11)Oct 23, 2025
Oct 23, 2025Clarification sought from Syngene International LtdOct 23, 2025
Oct 23, 2025Email Communication To Shareholders Under 100 Days Campaign - Saksham NiveshakOct 18, 2025
Oct 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ending September 30 2025.Oct 09, 2025
Oct 09, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Sep 27, 2025
Sep 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Investor PresentationSep 09, 2025
Sep 09, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 04, 2025
Sep 04, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 04, 2025
Sep 04, 2025Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)Sep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 20, 2025
Aug 20, 2025Intimation Of Cancellation Of Meeting With Analyst/Institutional InvestorAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Aug 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2025
Aug 04, 2025Grant Of Performance Share Units Under Syngene Long-Term Incentive Performance Share Plan 2023 (Plan)Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 29, 2025
Jul 29, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 24, 2025
Jul 24, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJul 24, 2025
Jul 24, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 23, 2025
Jul 23, 2025Intimation Of Change In Key Managerial Personnel (KMP) To Determine Materiality Of An Event Or InformationJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 23, 2025
Jul 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 23, 2025
Jul 23, 2025Unaudited Financial Results For Quarter Ended June 30 2025.Jul 23, 2025
Jul 23, 2025Board Meeting Outcome for Outcome Of The Board Meeting - July 23 2025Jul 23, 2025
Jul 23, 2025Mutual Fund Holdings
Mirae Asset Midcap Fund Direct - Growth 
UTI ELSS Tax Saver Fund Direct-Growth 
Kotak Arbitrage Fund Direct-Growth 
ICICI Prudential Equity Arbitrage Direct-Growth 
SBI Arbitrage Opportunities Fund Direct-Growth 
Aditya Birla Sun Life Arbitrage Fund Direct-Growth 
WhiteOak Capital Mid Cap Fund Direct - Growth 
Bandhan Innovation Fund Direct-Growth 
DSP Top 100 Equity Direct Plan-Growth 
Edelweiss Arbitrage Fund Direct-Growth 
Invesco India Arbitrage Fund Direct-Growth 
Tata Arbitrage Fund Direct - Growth 
LIC MF Flexi Cap Fund Direct-Growth 
Quantum ESG Best In Class Strategy Fund Direct - Growth 
PGIM India Healthcare Fund Direct-Growth Technical Indicators
RSI(14)
Neutral 42.69
ATR(14)
Less Volatile 14.91
STOCH(9,6)
Neutral 46.08
STOCH RSI(14)
Neutral 36.20
MACD(12,26)
Bearish -1.80
ADX(14)
Weak Trend 13.61
UO(9)
Bearish 32.49
ROC(12)
Downtrend And Accelerating -2.68
WillR(14)
Neutral -68.13
About Syngene International
Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene has facilities spanning 2.2 million sq. ft. in Bangalore, Hyderabad, and Mangalore. It provides end-to-end services within Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). Syngene offers various platforms and services including drug discovery, development capabilities, custom synthesis, process R&D, cGMP manufacturing, and clinical development services. The company has partnerships and collaborations with multiple global pharmaceutical and healthcare companies, expanding its research and manufacturing capabilities over the years.
Listing Date
11 Aug, 2015(10 Years,
12 days)
Website
Chairperson NameKiran Mazumdar Shaw
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
